Related Experiment Video
Updated: Jul 9, 2026

09:41
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Skin lesions induced by bortezomib
Ludek Pour1, Roman Hajek, Adam Zdenek
1Department of Internal Medicine-Hematooncology , Masaryk University Hospital, Jihlavska 20, Brno, 625 00, Czech Republic. lpour@fnbrno.cz
Haematologica
|February 9, 2006
Abstract:
We report on six cases of skin lesions induced by bortezomib in patients treated for relapsed multiple myeloma. The folliculitis-like rash appeared in the second cycle of bortezomib therapy. Therapy with prednisone led to rapid resolution of the skin lesions. Prednisone 10 mg before each infusion of bortezomib was necessary to prevent recurrence of the rash while antihistamines alone were ineffective.

